Open treatment of overweight binge eaters with phentermine and fluoxetine as an adjunct to cognitive-behavioral therapy

International Journal of Eating Disorders

Volumn 28, Issue 3, 2000, Pages 325-332

  Devlin, Michael J ^a   Goldfein, Juli A ^a   Carino, Janel S ^a   Wolk, Sara L ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Binge eating disorder; Pharmacotherapy; Psychotherapy

Indexed keywords

FLUOXETINE; PHENTERMINE;

ADULT; ANXIETY; ARTICLE; BEHAVIOR THERAPY; BINGE EATING DISORDER; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFICACY; FEEDING BEHAVIOR; FEMALE; HUMAN; INSOMNIA; MAINTENANCE THERAPY; OBESITY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; APPETITE DEPRESSANTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; HYPERPHAGIA; MIDDLE AGED; OBESITY; PHENTERMINE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0033838421     PISSN: 02763478     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-108X(200011)28:3<325::AID-EAT10>3.0.CO;2-3     Document Type: Article

References (33)

1. Appetite-suppressant drugs and the risk of primary pulmonary hypertension
2. Does interpersonal therapy help patients with binge eating disorder who fail to respond to cognitive-behavioral therapy?
3. Weight loss, cognitive-behavioral, and desipramine treatments in binge eating disorder. An additive design
4. Effect of a tricyclic antidepressant and opiate antagonist on binge-eating in normoweight bulimic and obese, binge-eating subjects
5. An inventory for measuring depression
6. Assessment and treatment of binge-eating disorder
7. Three psychological treatments for bulimia nervosa: A comparative trial
8. Cognitive-behavioral therapy for binge eating and bulimia nervosa: A comprehensive treatment manual
9. Fluvoxamine: An open pilot study in moderately obese female patients suffering from atypical eating disorders and episodes of bingeing
10. The hazards of fen-phen
11. The assessment of binge eating severity among obese persons
12. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation
13. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs
14. Phentermine and other monoamine-oxidase inihibitors may increase plasma serotonin when given with fenfluramines
15. A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge eaters and non-binge eaters
16. Cognitive treatment of binge eating vs. behavioral weight control in the treatment of binge eating disorder
17. Successful treatment of nonpurging bulimia nervosa with desipramine: A double-blind, placebo-controlled study
18. Metropolitan Life Insurance new weight standards for men and women
19. Cognitive-behavioral treatment of obese binge eaters
20. Eating patterns and obesity
21. d-Fenfluramine treatment of binge eating disorder
22. The Three-Factor Eating Questionnaire to measure dietary restraint, disinhibition and hunger
23. Rethinking side effects of the selective serotonin reuptake inhibitors: Sexual dysfunction and weight gain
24. Group cognitive-behavioral treatment for the nonpurging bulimic: An initial evaluation
25. Psychopharmacology of anorexia nervosa, bulimia nervosa, and binge eating
26. An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo
27. Group cognitive-behavioral therapy and group interpersonal psychotherapy for the nonpurging bulimic: A controlled comparison
28. Binge eating disorder: Current knowledge and future directions